Capital Performance Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Other funds holding TMO
Capital Performance Advisors's TMO Position: Q2 2026 in Review
Capital Performance Advisors reduced its Thermo Fisher Scientific (TMO) stake by 21% in Q2 2026, selling an estimated $57.1K and leaving 443 shares worth $222K. The position accounts for 0.01% of the portfolio, ranked #279.
Capital Performance Advisors first reported a position in TMO in Q3 2024 and has held it in 6 quarters since. The position peaked at $341K in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Capital Performance Advisors held 443 shares of Thermo Fisher Scientific worth $222K as of Q2 2026.
- Capital Performance Advisors sold 119 Thermo Fisher Scientific shares in Q2 2026, an estimated $57.1K.
- Thermo Fisher Scientific made up 0.01% of Capital Performance Advisors's portfolio in Q2 2026, its #279 holding.
- Capital Performance Advisors first reported a position in Thermo Fisher Scientific in Q3 2024 and has held it in 6 quarters since.
- Capital Performance Advisors's Thermo Fisher Scientific position peaked at $341K in Q4 2025.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Capital Performance Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.